Phenotypic Screening for Modern Drug Discovery

Plasmonica Bio delivers structured, reproducible datasets for high-quality go/no-go decision-making.

Novel high throughput in-vitro phenotyping in neuroscience, cardiology, and pulmonary models, with orthogonal screening available under one roof.

Explore the Platform
View Solutions

Model Characterization

  • Benchmark healthy vs. disease phenotypes

  • Validate models with live readouts

Functional Screening

  • Measure drug response on new axes

  • Reveal phenotypes missed by conventional assays

Program Support

  • Prioritize compounds with higher confidence data

  • We support pilot studies, screening campaigns, and strategic collaborations

More Predictive Biology • Better Differentiation • De-risked Decisions • Flexible Engagement